The experimental realization of a continuous preferential crystallization process, consisting of two mixed-flow crystallizers coupled via crystal-free liquid exchange streams and with only the liquid phases operating continuously, is addressed. Experiments in triplicate, using the conglomerate-forming system of dl-asparagine monohydrate in water, were conducted, and the achievement of nearly racemic composition of the liquid phase in the crystallizers was verified. An experiment was also carried out using seed crystals of a smaller average particle size than used in the reference experiments. Successful enantioseparation by crystal growth, with the repeatability being within ±10% deviation, was obtained. However, slow crystal growth, due to...
The separation of enantiomers is of great importance due to their possible differences in therapeuti...
Pure enantiomers are of large interest for several industries. Chemical synthesis is frequently not ...
Driven by the policy of regulatory authorities such as US Food and Drug Administration and the EU Co...
A mathematical model describing the separation of enantiomers by simultaneous preferential crystalli...
Chiral molecules can be a particular challenge when used in drugs because of the existence of their ...
An increasing demand for pure enantiomers in last years is motivated by the high interest of the pha...
Separating enantiomers is of persistent importance due to the possible differences in biological eff...
The separation of chiral compounds is of large interest since most of the (bio-)organic molecules ar...
Growing demands for products with constant high quality make continuous crystallization very attract...
The separation of chiral compounds is of large interest since most of the (bio-)organic molecules ar...
In the recent years, the rise of effort for improving of already established separation process has ...
An attractive process for gaining pure enantiomers from racemic mixtures is the so-called preferenti...
The focus of this work is to study the enantioseparation of conglomerate forming systems using an in...
Organic molecules which are interesting for the pharmaceutical, food and agricultural industry often...
Usually racemic mixtures of chrial substances are produced in chemical industry although in most cas...
The separation of enantiomers is of great importance due to their possible differences in therapeuti...
Pure enantiomers are of large interest for several industries. Chemical synthesis is frequently not ...
Driven by the policy of regulatory authorities such as US Food and Drug Administration and the EU Co...
A mathematical model describing the separation of enantiomers by simultaneous preferential crystalli...
Chiral molecules can be a particular challenge when used in drugs because of the existence of their ...
An increasing demand for pure enantiomers in last years is motivated by the high interest of the pha...
Separating enantiomers is of persistent importance due to the possible differences in biological eff...
The separation of chiral compounds is of large interest since most of the (bio-)organic molecules ar...
Growing demands for products with constant high quality make continuous crystallization very attract...
The separation of chiral compounds is of large interest since most of the (bio-)organic molecules ar...
In the recent years, the rise of effort for improving of already established separation process has ...
An attractive process for gaining pure enantiomers from racemic mixtures is the so-called preferenti...
The focus of this work is to study the enantioseparation of conglomerate forming systems using an in...
Organic molecules which are interesting for the pharmaceutical, food and agricultural industry often...
Usually racemic mixtures of chrial substances are produced in chemical industry although in most cas...
The separation of enantiomers is of great importance due to their possible differences in therapeuti...
Pure enantiomers are of large interest for several industries. Chemical synthesis is frequently not ...
Driven by the policy of regulatory authorities such as US Food and Drug Administration and the EU Co...